Canada has an opportunity to prevent sustained Clade I mpox transmission, but only if decisive action is taken now.

After a review of evidence, the UK Health Security Agency (HSA) said today that it no longer classifies clade 1a and 1b mpox ...

Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

On August 13, 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) declared the multi-country mpox ...

Think you clocked all the references to A Ballad of Songbirds & Snakes in Sunrise on the Reaping? Think again.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third meeting of the ...